Research
Saint Louis, MO, (www.leebio.com)
Researchers are excited that Lee Bio's Product line now includes biomarkers such as BNP and NT-proBNP since these markers have been reported as the 'fatal finish line' for most cardiovascular disorders. In addition there has been an increased demand for Cardiac TROPONIN'S with major diagnostic companies since they have proven to simplify the diagnosis of myocardial infarction. Sales for Lee Bio's inflammatory biomarkers such as C-REACTIVE PROTEIN and MYELOPEROXIDASE have doubled since the beginning of the year because research continues to show they help identify the patients who would benefit the most from specific treatments for coronary artery disease
Biomarkers found in the blood are helping researchers predict, diagnose and treat heart attacks better than ever before, Lee Biosolutions President Burton Lee said. Researchers use these materials to advance their understanding of the critical role they play in heart-related illness.
According to Lee Biosolutions President Burton Lee, the demand for research proteins have increased significantly over the past 12 months. “We operate with one ear constantly tuned to the diagnostic manufacturing and pharmaceutical community,” Lee said. “This helps us stay on top of the latest cardiovascular research and gives us the information we need to stay ahead of their demands
Lee Biosolutions Inc is a leader in the development and marketing of high valued specialty products such as , recombinant proteins, coenzymes, human and animal antigens, antibodies for both research and industrial applications.
Working closely with major diagnostic companies and clinical researchers world wide in cell biology and medicine, Lee Biosolutions, Inc delivers over 400 products to more than 40 countries around the globe. To learn more about how LEE BIOSOLUTIONS helps to make research work, visit www.leebio.com
